Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection.

Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection.

Item
http://www.wikidata.org/entity/Q34000140
A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalisA replication study of the association between the IL12B promoter allele CTCTAA and susceptibility to cerebral malaria in Thai population.Low interleukin-12 activity in severe Plasmodium falciparum malariaPolymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya.Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemiaEarly nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria.Cytokines in the pathogenesis of and protection against malariaSevere malarial anemia: innate immunity and pathogenesis.Host candidate gene polymorphisms and associated clearance of P. falciparum amodiaquine and fansidar resistance mutants in children less than 5 years in Cameroon.Relationship between plasma Interleukin-12 (IL-12) and IL-18 levels and severe malarial anemia in an area of holoendemicity in western Kenya.Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice.IL12Rβ1: the cytokine receptor that we used to know.Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso.Prevalence of malaria, prevention measures, and main clinical features in febrile children admitted to the Franceville Regional Hospital, Gabon.Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population.Antimalarial drugs clear resistant parasites from partially immune hosts.Sequential Plasmodium chabaudi and Plasmodium berghei infections provide a novel model of severe malarial anemia.
P2860

Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection.

Item
http://www.wikidata.org/entity/Q34000140
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Therapy with a combination of ...... duces immunity to reinfection.
@ast
Therapy with a combination of ...... duces immunity to reinfection.
@en
Therapy with a combination of ...... duces immunity to reinfection.
@nl
type
label
Therapy with a combination of ...... duces immunity to reinfection.
@ast
Therapy with a combination of ...... duces immunity to reinfection.
@en
Therapy with a combination of ...... duces immunity to reinfection.
@nl
prefLabel
Therapy with a combination of ...... duces immunity to reinfection.
@ast
Therapy with a combination of ...... duces immunity to reinfection.
@en
Therapy with a combination of ...... duces immunity to reinfection.
@nl
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932
P1433
P1476
Therapy with a combination of ...... nduces immunity to reinfection
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932